A new trading day began on Friday, with Boston Scientific Corp (NYSE: BSX) stock price up 0.17% from the previous day of trading, before settling in for the closing price of $102.96. BSX’s price has ranged from $74.01 to $108.94 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -17.84%. Meanwhile, its annual earnings per share averaged 18.85%. With a float of $1.47 billion, this company’s outstanding shares have now reached $1.48 billion.
Considering the fact that the conglomerate employs 53000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 63.23%, operating margin of 16.77%, and the pretax margin is 16.22%.
Boston Scientific Corp (BSX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of Boston Scientific Corp is 0.58%, while institutional ownership is 92.19%. The most recent insider transaction that took place on Aug 01 ’25, was worth 5,231,670. In this transaction EVP & Group Pres, Cardiology of this company sold 50,000 shares at a rate of $104.63, taking the stock ownership to the 178,342 shares. Before that another transaction happened on Aug 01 ’25, when Company’s EVP& Grp Pres, MedSurg & APAC sold 17,313 for $104.63, making the entire transaction worth $1,811,520. This insider now owns 23,600 shares in total.
Boston Scientific Corp (BSX) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of 0.63 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.76 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 18.85% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 15.23% during the next five years compared to -17.84% drop over the previous five years of trading.
Boston Scientific Corp (NYSE: BSX) Trading Performance Indicators
Here are Boston Scientific Corp’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.82. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.26. Likewise, its price to free cash flow for the trailing twelve months is 43.85.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.68, a number that is poised to hit 0.72 in the next quarter and is forecasted to reach 3.40 in one year’s time.
Technical Analysis of Boston Scientific Corp (BSX)
Compared to the last year’s volume of 7.65 million, its volume of 5.81 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 24.72%.
During the past 100 days, Boston Scientific Corp’s (BSX) raw stochastic average was set at 74.74%, which indicates a significant increase from 20.98% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 2.06 in the past 14 days, which was lower than the 2.20 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $103.64, while its 200-day Moving Average is $98.36.
